Evidence map›Paper›PMID 30547048›Full record

ArticleMolecular therapy. Methods & clinical development2018

Barcoding of Macaque Hematopoietic Stem and Progenitor Cells: A Robust Platform to Assess Vector Genotoxicity.

Idalia M Yabe, Lauren L Truitt, Diego A Espinoza, Chuanfeng Wu, Samson Koelle, Sandhya Panch, Marcus A F Corat, Thomas Winkler, Kyung-Rok Yu, So Gun Hong and 5 more

Open access · goldAbstract read
In one paragraph

Article in Molecular therapy. Methods & clinical development, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 2 countries.

Idalia M YabeHematology Branch, National Heart, Lung and Blood Institute, NIH, Bethesda, MD 20892, USA.
Lauren L TruittHematology Branch, National Heart, Lung and Blood Institute, NIH, Bethesda, MD 20892, USA.
Diego A EspinozaHematology Branch, National Heart, Lung and Blood Institute, NIH, Bethesda, MD 20892, USA.
Chuanfeng WuHematology Branch, National Heart, Lung and Blood Institute, NIH, Bethesda, MD 20892, USA.
Samson KoelleHematology Branch, National Heart, Lung and Blood Institute, NIH, Bethesda, MD 20892, USA.
Sandhya PanchHematology Branch, National Heart, Lung and Blood Institute, NIH, Bethesda, MD 20892, USA.
Marcus A F CoratHematology Branch, National Heart, Lung and Blood Institute, NIH, Bethesda, MD 20892, USA.
Thomas WinklerHematology Branch, National Heart, Lung and Blood Institute, NIH, Bethesda, MD 20892, USA.
Kyung-Rok YuHematology Branch, National Heart, Lung and Blood Institute, NIH, Bethesda, MD 20892, USA.
So Gun HongHematology Branch, National Heart, Lung and Blood Institute, NIH, Bethesda, MD 20892, USA.
Aylin BonifacinoHematology Branch, National Heart, Lung and Blood Institute, NIH, Bethesda, MD 20892, USA.
Allen KrouseHematology Branch, National Heart, Lung and Blood Institute, NIH, Bethesda, MD 20892, USA.
Mark MetzgerHematology Branch, National Heart, Lung and Blood Institute, NIH, Bethesda, MD 20892, USA.
Robert E DonahueHematology Branch, National Heart, Lung and Blood Institute, NIH, Bethesda, MD 20892, USA.
Cynthia E DunbarHematology Branch, National Heart, Lung and Blood Institute, NIH, Bethesda, MD 20892, USA.
National Heart Lung and Blood Institute · USGeorgetown University · US

Funding

Optimization of gene transfer safety and efficacy focusing on the NHP modelZIAHL002339 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI DUNBAR, CYNTHIA E · 2009 to 2025
$26.8M
Retroviral Mediated Gene Transfer Into Primate Hematopoietic CellsZIAHL002338 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI HONG, SO GUN · 2019 to 2025
$26.3M
Understanding hematopoietic stem cell mobilization and engraftmentZIAHL006063 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI DUNBAR, CYNTHIA E · 2010 to 2025
$23.5M
6 · The paper itself

Abstract

Gene therapies using integrating retrovirus vectors to modify hematopoietic stem and progenitor cells have shown great promise for the treatment of immune system and hematologic diseases. However, activation of proto-oncogenes via insertional mutagenesis has resulted in the development of leukemia. We have utilized cellular bar coding to investigate the impact of different vector designs on the clonal behavior of hematopoietic stem and progenitor cells (HSPCs) during

Indexed as

gene therapygenotoxicitylentivirusnon-human primate

Identifiers

PMID30547048
PMCPMC6258888
OpenAlexW2898460507

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.